Research project
DAME: Treatment of >400μ central-involving Diabetic macular oedema with fAricimab versus combined Faricimab and subthreshold Micropulse lasEr (SML) applied when central retinal thickness is reduced below 400μ (DAME): A randomised clinical trial.
-
Lead researchers:
-
Status:Active
